Bleeding disorders under hormonal contraceptives

被引:0
作者
Niggli, Angela [1 ]
Merki-Feld, Gabriele Susanne [1 ]
机构
[1] Univ Spital Zurich, Klin Reprod Endokrinol, Frauenklin Str 10, CH-8091 Zurich, Switzerland
来源
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2024年
关键词
Contraception; Uterine hemorrhage; Intrauterine devices; Hormones; Watchful waiting; MU-G ETHINYLESTRADIOL; CYCLE CONTROL; LEVONORGESTREL; TOLERABILITY; EFFICACY; ACETATE;
D O I
10.1007/s10304-024-00597-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hormonal contraceptives, such as pills and intrauterine systems (IUS), are among the most commonly used contraceptive methods. Methods using only gestagens, such as progesterone-only pills, injections, implants or IUS are reliable contraceptive options for almost all women. Unscheduled bleeding is a common side effect of hormonal contraceptives, can vary depending on the contraceptive method and the exact causes are still unclear. Unacceptable bleeding is stressful for the user and is one of the most common reasons for discontinuing a contraceptive method. Treatment options for bleeding irregularities include the administration of estrogens, gestagens or nonsteroidal anti-inflammatory drugs.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 32 条
[11]   Progestogen-only contraception and bone mineral density: a systematic review [J].
Curtis, KM ;
Martins, SL .
CONTRACEPTION, 2006, 73 (05) :470-487
[12]   Three-year continuation of reversible contraception [J].
Diedrich, Justin T. ;
Zhao, Qiuhong ;
Madden, Tessa ;
Secura, Gina M. ;
Peipert, Jeffrey F. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (05) :662.e1-662.e8
[13]   Long-term utilization and continuation of intrauterine devices [J].
Diedrich, Justin T. ;
Madden, Tessa ;
Zhao, Qiuhong ;
Peipert, Jeffrey F. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (06) :822-+
[14]   A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 mu g ethinylestradiol 75 mu g gestodene and 30 mu g ethinylestradiol 75 mu g gestodene, with respect to efficacy, cycle control, and tolerance [J].
Endrikat, J ;
Muller, U ;
Dusterberg, B .
CONTRACEPTION, 1997, 55 (03) :131-137
[15]   Therapeutic Options for Unscheduled Bleeding Associated with Long-Acting Reversible Contraception [J].
Friedlander, EmmaKate ;
Kaneshiro, Bliss .
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2015, 42 (04) :593-+
[16]   Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review [J].
Godfrey, Emily M. ;
Whiteman, Maura K. ;
Curtis, Kathryn M. .
CONTRACEPTION, 2013, 87 (05) :567-575
[17]   Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems [J].
Goldthwaite, Lisa M. ;
Creinin, Mitchell D. .
CONTRACEPTION, 2019, 100 (02) :128-131
[18]   Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices [J].
Heinemann, Klaas ;
Reed, Suzanne ;
Moehner, Sabine ;
Do Minh, Thai .
CONTRACEPTION, 2015, 91 (04) :280-283
[19]   Unscheduled bleeding in continuous combined hormone therapy users [J].
Hickey, Martha ;
Ameratunga, Devini ;
Marino, Jennifer L. .
MATURITAS, 2011, 70 (04) :400-403
[20]  
Kimble Thomas, 2020, Contracept X, V2, P100020, DOI 10.1016/j.conx.2020.100020